HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

SUN 9216

tissue plasminogen activator in which Asn117 is replaced by Gln; reduces the area of cerebral infarction
Also Known As:
SUN-9216; SUN9216; lanoteplase
Networked: 21 relevant articles (4 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Llevadot, J: 4 articles (11/2001 - 11/2000)
2. Giugliano, R P: 3 articles (11/2001 - 07/2001)
3. Antman, E M: 3 articles (11/2001 - 07/2001)
4. Schröder, K: 2 articles (11/2001 - 08/2001)
5. Tebbe, U: 2 articles (11/2001 - 11/2001)
6. Schröder, R: 2 articles (11/2001 - 08/2001)
7. Wegscheider, K: 2 articles (11/2001 - 08/2001)
8. Zeymer, U: 2 articles (11/2001 - 08/2001)
9. Gurfinkel, E P: 2 articles (11/2001 - 09/2001)
10. Braunwald, E: 2 articles (11/2001 - 09/2001)

Related Diseases

1. Myocardial Infarction
2. Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
3. Intracranial Hemorrhages (Intracranial Hemorrhage)
4. Cerebral Infarction
5. Stroke (Strokes)

Related Drugs and Biologics

1. Tissue Plasminogen Activator (Alteplase)
2. Heparin (Liquaemin)
3. glucuronyl glucosamine glycan sulfate (Vessel)
4. tenecteplase
5. reteplase
6. Plasminogen Activators (Plasminogen Activator)
7. Fibrinolytic Agents (Antithrombotic Agents)
8. monteplase
9. YM 866
10. S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)

Related Therapies and Procedures

1. Thrombolytic Therapy